Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 2, 2003, Pages 624-630

  Raghavendra, Vasudeva ^a   Tanga, Flobert ^a   Deleo, Joyce A ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIGEN; CYTOKINE; DNA; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE ANTIGEN COMPLEX 1; MINOCYCLINE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL BEHAVIOR; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPERALGESIA; IMMUNE RESPONSE; INFLAMMATION; LUMBAR SPINAL CORD; MALE; MICROGLIA; NERVE TRANSECTION; NEUROPATHIC PAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL NERVE INJURY; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CYTOKINES; GENE EXPRESSION; HYPERALGESIA; HYPERSENSITIVITY; MICROGLIA; MINOCYCLINE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SPINAL NERVES;

EID: 0037622717     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.052407     Document Type: Article

References (41)

1. Aloisi F (2001) Immune function of microglia. Glia 36:165-179.
2. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, and Abramson SB (1996) A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 93:14014-14019.
3. Aronson AL (1980) Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc 176:1061-1068.
4. Banati RB, Gehrmann J, Schubert P, and Kreutzberg GW (1993) Cytotoxicity of microglia. Glia 7:111-118.
5. Bao L, Zhu Y, Elhassan AM, Qinyang W, Xiao B, Zhu J, and Lindgren JU (2001) Adjuvant-induced arthritis: IL-1β, IL-6 and TNF-α are up-regulated in the spinal cord. Neuroreport 12:3905-3908.
6. Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, et al. (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6:797-801.
7. Colburn RW, Rickman AJ, and DeLeo JA (1999) The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157:289-304.
8. Covino BG, Dubner R, Gybels J, Losterlitz HW, Liebeskind JC, Sternbach RA, Vylicky L, Yamamura H, and Zimmerman M (1980) Ethical standards for investigations of experimental pain in animals. Pain 9:141-143.
9. DeLeo JA and Colburn RW (1999) Proinflammatory cytokines and glial cells: their role in neuropathic pain, in Cytokines and Pain (Watkins LR and Maier SF) pp 159-181, Birkhauser Verlag, Basel.
10. DeLeo JA and Yezierski RP (2001) The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90:1-6.
11. Dong Y and Benveniste EN (2001) Immune function of astrocytes. Glia 36:180-190.
12. Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales TR, Triarhou LC, Chernet E, Perry KW, Nelson DL, et al. (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98:14669-14674.
13. Eriksson NP, Persson JKE, Aldskogius H, and Svensson M (1997) A quantitative analysis of the glial cell reaction in primary sensory termination areas following sciatic nerve injury and treatment with nerve growth factor in the adult rat. Exp Brain Res 114:393-404.
14. Gilmore SA and Kane CJM (1998) Microglia, but not astrocytes, react to sciatic nerve injury in aging rats. Brain Res 806:113-116.
15. Hopkins SJ and Rothwell NJ (1995) Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci 18:83-88.
16. Kloppenburg M, Brinkman BMN, Rooij-Dijk HH, Miltenburg AMM, Daha MR, Breedveld FC, Dijkmans BAC, and Verweij CL (1996) The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes. Antimicrob Agents Chemother 40:934-940.
17. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
18. Meller ST, Dyskstra C, Grzybycki D, Murphy S, and Gebhart GF (1994) The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33:1471-1478.
19. Milligan ED, O'Connor KA, Nguyen KT, Armstrong CB, Twining C, Gaykema RPA, Holguin A, Martin D, Maier SF, and Watkins LR (2003) Intrathecal HIV-1 envelope glycoprotein gp 120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J Neurosci 21:2808-2819.
20. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor KA, Poole S, Tracey K, Martin D, Maier SF, and Watkins LR (2003) Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 23:1026-1040.
21. Popovich PG, Wei P, and Stokes BT (1997) Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 377:443-464.
22. Raghavendra V and DeLeo JA (2003) The role of astrocytes and microglia in persistent pain, in Non-Neuronal Cells in the Nervous System: Function and Dysfunction (Hertz L ed) Elsevier, Amsterdam, in press.
23. Raghavendra V, Rutkowski MD, and DeLeo JA (2002) The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham operated rats. J Neurosci 22:9980-9989.
24. Raghavendra V, Tanga F, Rutkowski MD, and DeLeo JA (2003) Anti-hyperalgesic and morphine sparing actions of propentofylline following nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain, in press.
25. Sanchez Mejia RO, Ona VO, Li M, and Friedlander RM (2001) Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage and neurological dysfunction. Neurosurgery 48:1393-1399.
26. Stein C, Gramsch C, and Herz A (1990) Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J Neurosci 10:1292-1298.
27. Svensson M, Eriksson P, Persson JK, Molander C, Arvidsson J, and Aldskogius H (1993) The response of central glia to peripheral nerve injury. Brain Res Bull 30:499-506.
28. Sweitzer SM, Hickey WF, Rutkowski MD, Pahl JL, and DeLeo JA (2002) Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain. Pain 100:163-170.
29. Sweitzer SM, Schubert P, and DeLeo JA (2001) Propentofylline, a glial modulating agent, exhibits anti-allodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 297:1210-1217.
30. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, and Koistinaho J (2001a) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation, proliferation of microglia. J Neurosci 21:2580-2588.
31. Tikka TM and Koistinaho JE (2001) Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166:7527-7533.
32. Tikka T, Usenius T, Tenhunen M, Keinanen R, and Koistinaho J (2001b) Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic protect neurons against apoptosis induced by ionizing radiation. J Neurochem 78:1409-1414.
33. Vila M, Jackson Lewis V, Guegan C, Wu DC, Teismann P, Choi DK, Tieu K, and Przedborski S (2001) The role of glial cells in Parkinson's disease. Curr Opin Neurol 14:483-489.
34. Watkins LR, Martin D, Ulrich P, Tracey KJ, and Maier SF (1997) Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71:225-235.
35. Watkins LR, Milligan ED, and Maier SF (2001a) Spinal cord glia: new players in pain. Pain 93:201-205.
36. Watkins LR, Milligan ED, and Maier SF (2001b) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450-455.
37. Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi D, Ischiropoulos H, and Przedborski S (2002) Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22:1763-1771.
38. Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, and Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769-15774.
39. Yrjanheikki J, Tikka T, Keinanen R, Goldsteins G, Chan PH, and Koistinaho J (1999) A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 96:13496-13500.
40. Zhang SC, Goetz BD, and Duncan ID (2003) Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors. Glia 41:191-198.
41. Zhu S, Stavrovskaya IG, Drozda M, Kim BYS, Ona V, Li M, Sarang S, Liu AS, Hartley DM, Wu DC, et al. (2002) Minocycline inhibits cytochrome-c release and delays progression of amyotrophic lateral sclerosis in mice. Nature (Lond) 417:74-78.